The aim of this study was to investigate whether treatment with rapamycin plus vildagliptin restores beta-cell function in patients with long-standing type 1 diabetes.
Rapamycin Plus Vildagliptin to Recover ß Cell Function in Long Standing Type 1 Diabetes: A Double Blind Randomized Trial / Bolla, Andrea Mario; Gandolfi, Alessandra; Borgonovo, Elisa; Laurenzi, Andrea; Caretto, Amelia; Molinari, Chiara; Catalano, Roberta Sara; Bianconi, Eleonora; Monti, Paolo; Sordi, Valeria; Pellegrini, Silvia; Lampasona, Vito; Costa, Sabrina; Scavini, Marina; Bosi, Emanuele; Piemonti, Lorenzo. - In: THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM. - ISSN 0021-972X. - (2020). [Epub ahead of print] [10.1210/clinem/dgaa791]
Rapamycin Plus Vildagliptin to Recover ß Cell Function in Long Standing Type 1 Diabetes: A Double Blind Randomized Trial
Bosi, Emanuele;Piemonti, Lorenzo
Ultimo
2020-01-01
Abstract
The aim of this study was to investigate whether treatment with rapamycin plus vildagliptin restores beta-cell function in patients with long-standing type 1 diabetes.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
